Archive - November 2017

People undergoing cancer treatment often report experiencing "chemo brain," or states of confusion and cognitive impairment due to aggressive chemotherapy treatment. But new research suggests that these cognitive problems might start earlier, with the development of cancer tumors. Researchers at the Baycrest Centre for Geriatric Care in Toronto, Canada, conducted a study focusing on the "chemo brain" effect, with the purpose of understanding to what extent these states of cognitive impairment

Smoking is known to increase the risk of 14 different types of cancer and is responsible for 30% of cancer deaths according to the American Cancer Society. Breast cancer looks set to become the 15th type to be added to the list after a major studypublished this week in Breast Cancer Research showed that smoking increases a woman’s risk of developing breast cancer by up to 35%. The Generations Study collected data from the women for an average

With the support of the FWF, an oncologist found a biomarker for breast cancer having a poor prognosis and developed two viable methods to detect it in tissue samples. Breast cancer is the most frequent malignant tumour in women worldwide. In Austria, about 5,500 women develop it each year and 1,500 die of it despite the availability of an early detection programme. When a lump is found in a breast, the next step in clinical practice is a biopsy. Although no remedy exists for

Many people diagnosed with a form of cancer also experience post-traumatic stress disorder, and for some, this persists and sometimes worsens with time, even after successful cancer treatment. Post-traumatic stress disorder (PTSD) is a psychological condition that develops in the aftermath of a particularly distressing event. The condition can be debilitating for many; it can lead to avoidance of places and contexts reminiscent of the trauma and may result in social isolation and negative

Therafirm’s Ease line of compression hosiery debuted in 2014 and quickly rose in popularity among customers due to their construction from ultra-stretchy and super soft yarns. The product resulting from these unique yarns is easy to put on, extra comfortable, and beautifully fashionable—everything that other compression hosiery was not. Due to overwhelming positive feedback on the product line, Therafirm recently expanded the line to fit more patients, with the introduction of extra-large

Breastfeeding for at least two months cuts a baby's risk of Sudden Infant Death Syndrome almost in half, a sweeping new international study has found. The study determined that mothers do not need to breastfeed exclusively for their baby to get the benefit, potentially good news for moms who can't or choose not to rely solely on breastfeeding. "These results are very powerful! Our study found that babies who are breastfed for at least two months have a significant reduction in their

A recent analysis has found that even 20 years after receiving a diagnosis of estrogen receptor-positive breast cancer, the risk of the cancer's return looms large. Should treatment be extended? Estrogen receptor-positive (ER-positive) breast cancer is the most common breast cancer type, accounting for around 80 percent of all breast cancer cases. In short, ER-positive breast cancer flourishes in response to estrogen. The standard treatments for

Lymphedema is swelling of the arm, hand, chest wall, trunk, back, or other body part caused by lymph fluid collecting in tissue after surgery, especially breast cancer surgery that removes underarm (axillary) lymph nodes. Edema is the medical term for swelling, so swelling caused by lymph fluid is "lymphedema." Lymphedema can reduce your ability to use your arm or the affected area, as well as increase your risk for infection in the area. Lymphedema also can be painful, can change the quality

The genetic causes of breast cancer just got clearer. Researchers from 300 institutions around the world combined forces to discover 72 previously unknown gene mutations that lead to the development of breast cancer. Two studies describing their work published Monday in the journals Nature and Nature Genetics. The teams found that 65 of the newly identified genetic variants are common among women with breast cancer. The remaining seven mutations predispose women to developing